The efficacy and tolerability of dapsone 5% gel in female vs male patients with facial acne vulgaris: Gender as a clinically relevant outcome variable

Journal of Drugs in Dermatology

Volumn 11, Issue 12, 2012, Pages 1417-1421

  Tanghetti, Emil ^a   Harper, Julie C ^b   Oefelein, Michael G ^c  

^a Center for Dermatology and Laser Surgery   (United States)

^b Dermatology and Skin Care Center of Birmingham   (United States)

^c Digirad Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAPSONE;

ACNE VULGARIS; ARTICLE; CHILD; COMEDO; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DRY SKIN; ERYTHEMA; FACIAL ACNE VULGARIS; FEMALE; GEL; HUMAN; MAJOR CLINICAL STUDY; MALE; OILY SKIN; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL; PUSTULE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHOOL CHILD; SCORING SYSTEM; SEX DIFFERENCE; SKIN; SKIN ABRASION; TREATMENT RESPONSE;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; CHILD; DAPSONE; DOUBLE-BLIND METHOD; FEMALE; GELS; HUMANS; MALE; SEX CHARACTERISTICS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84871089751     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Collier CN, Harper JC, Cafardi JA, et al. The prevalence of acne in adults 20 years and older. J Am Acad Dermatol. 2008;58(1):56-59. (Pubitemid 350298137)
2. Wilhelm KP, Cua AB, Maibach HI. Skin aging. Effect on transepidermal water loss, stratum corneum hydration, skin surface pH, and casual sebum content. Arch Dermatol. 1991;127(12):1806-1809.
3. Ohman H, Vahlquist A. In vivo studies concerning a pH gradient in human stratum corneum and upper epidermis. Acta Derm Venereol. 1994;74(5):375-379. (Pubitemid 24305854)
4. Blank IH. Measurement of pH on the skin surface. II. pH of the exposed surfaces of adults with no apparent skin lesions. J Invest Dermatol. 1939;2:75-79.
5. Jacobi U, Gautier J, Sterry W, Lademann J. Gender-related differences in the physiology of the stratum corneum. Dermatology. 2005;211(4):312-317. (Pubitemid 41642103)
6. Kim MK, Patel RA, Shinn AH, et al. Evaluation of gender difference in skin type and pH. J Dermatol Sci. 2006;41(2):153-156. (Pubitemid 43088868)
7. Ehlers C, Ivens UI, Møller ML, Senderovitz T, Serup J. Females have lower skin surface pH than men. A study on the surface of gender, forearm site variation, right/left difference and time of the day on the skin surface pH. Skin Res Technol. 2001;7(2):90-94. (Pubitemid 32409575)
8. Seidenari S, Pagnoni A, Di Nardo A, Giannetti A. Echographic evaluation with image analysis of normal skin: variations according to age and sex. Skin Pharmacol. 1994;7(4):201-209. (Pubitemid 24116811)
9. Sjöström L, Smith U, Krotkiewski M, Björntorp P. Cellularity in different regions of adipose tissue in young men and women. Metabolism. 1972;21(12):1143-1153.
10. Bolognia JL. Aging skin. Am J Med. 1995;98(1A):99S-103S.
11. Denda M, Koyama J, Hori J, et al. Age- and sex-dependent change in stratum corneum sphingolipids. Arch Dermatol Res. 1993;285(7):415-417. (Pubitemid 23284623)
12. Strauss JS, Kligman AM, Pochi PE. The effect of androgens and estrogens on human sebaceous glands. J Invest Dermatol. 1962;39:139-155.
13. Guy R, Ridden C, Kealey T. The improved organ maintenance of the human sebaceous gland: modeling in vitro the effects of epidermal growth factor, androgens, estrogens, 13-cis-retinoic acid, and phenol red. J Invest Dermatol. 1996;106(3):454-460. (Pubitemid 26117583)
14. Pochi PE, Strauss JS, Downing DT. Age-related changes in sebaceous gland activity. J Invest Dermatol. 1979;73(1):108-111. (Pubitemid 10136119)
15. Draelos ZD, Carter E, Maloney JM, et al. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris. J Am Acad Dermatol. 2007;56(3):439.e1-e10.
16. Lucky AW, Maloney JM, Roberts J, et al. Dapsone gel 5% for the treatment of acne vulgaris: safety and efficacy of long-term (1 year) treatment. J Drugs Dermatol. 2007;6(10):981-987.
17. Fleischer AB Jr, Shalita A, Eichenfeld LF, et al. Dapsone gel 5% in combination with adapalene gel 0.1$, benzoyl peroxide gel 4% or moisturizer for the treatment of acne vulgaris: a 12-week, randomized, double-blind study. J Drugs Dermatol. 2010;9(1):33-40.
18. Tanghetti E, Dhawan S, Green L, et al. Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone 5% gel in combination with tazarotene 0.1% cream in patients with acne vulgaris. J Drugs Dermatol. 2011;10(7):783-792.
19. Dao H Jr, Kazin RA. Gender differences in skin: a review of the literature. Gend Med. 2007;4(4):308-328.
20. Zaghloul SS, Cunliffe WJ, Goodfield MJ. Objective assessment of compliance with treatments in acne. Br J Dermatol. 2005;152(5):1015-1021. (Pubitemid 40704945)
21. Rapp DA, Brenes GA, Feldman SR, et al. Anger and acne: implications for quality of life, patient satisfaction and clinical care. Br J Dermatol. 2004;151(1):183-189. (Pubitemid 39061297)
22. Jones-Caballero M, Pedrosa E, Peñas PF. Self-reported adherence to treatment and quality of life in mild to moderate acne. Dermatology. 2008;217(4):309-314.
23. Tan JK, Balagurusamy M, Fung K, et al. Effect of quality of life impact and clinical severity on adherence to topical acne treatment. J Cutan Med Surg. 2009;13(4):204-208.
24. Lott R, Taylor SL, O'Neill JL, Krowchuk DP, Feldman SR. Medication adherence among acne patients: a review. J Cosmet Dermatol. 2010;9(2):160-166.
25. Yan AC, Treat JR. Beyond first-line treatment: management strategies for maintaining acne improvement and compliance. Cutis. 2008;82(2 suppl 1):18-25.
26. Akomeah FK. Topical dermatological drug delivery: quo vadis? Curr Drug Deliv. 2010;7(4):283-296.
27. Castro GA, Ferreira LA. Novel vesicular and particulate drug delivery systems for topical treatment of acne. Expert Opin Drug Deliv. 2008;5(6):665-679. (Pubitemid 351998256)
28. Olsen NJ, Kovacs WJ. Gonadal steroids and immunity. Endocr Rev. 1996;17(4):369-384. (Pubitemid 26277980)
29. Ottaviani M, Alestas T, Flori E, Mastrofrancesco A, Zouboulis CC, Picardo M. Peroxidated squalene induces the production of inflammatory mediators in HaCaT keratinocytes: a possible role in acne vulgaris. J Invest Dermatol. 2006;126(11):2430-2437. (Pubitemid 44582265)
30. Georgel P, Crozat K, Lauth X, et al. A toll-like receptor 2-responsive lipid effector pathway protects mammals against skin infections with gram-positive bacteria. Infect Immun. 2005;73(8):4512-4521. (Pubitemid 41105605)
31. Williams SO, Long S, Allen J, Wells ML. Scale-up of an oil/water cream containing 40% diethylene glycol monoethyl ether. Drug Dev Ind Pharm. 2000;26(1):71-77. (Pubitemid 30075304)